217 related articles for article (PubMed ID: 31432403)
1. The Human Brain Proteome Project: Biological and Technological Challenges.
Fernández-Irigoyen J; Corrales F; Santamaría E
Methods Mol Biol; 2019; 2044():3-23. PubMed ID: 31432403
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
[TBL] [Abstract][Full Text] [Related]
3. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
5. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics to Tackle the Biological Meaning of Human Cerebrospinal Fluid Proteome.
Trindade F; Nogueira-Ferreira R; Bastos P; Amado F; Ferreira R; Vitorino R
Methods Mol Biol; 2019; 2044():393-553. PubMed ID: 31432428
[TBL] [Abstract][Full Text] [Related]
7. Neuroproteomics Studies: Challenges and Updates.
Ramadan N; Ghazale H; El-Sayyad M; El-Haress M; Kobeissy FH
Methods Mol Biol; 2017; 1598():3-19. PubMed ID: 28508355
[TBL] [Abstract][Full Text] [Related]
8. Advancing cerebrospinal fluid biomarker discovery by mass spectrometry.
Gobom J
Neurodegener Dis Manag; 2015 Oct; 5(5):371-3. PubMed ID: 26477620
[No Abstract] [Full Text] [Related]
9. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
[TBL] [Abstract][Full Text] [Related]
10. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
11. The proteomic toolbox for studying cerebrospinal fluid.
van Gool AJ; Hendrickson RC
Expert Rev Proteomics; 2012 Apr; 9(2):165-79. PubMed ID: 22462788
[TBL] [Abstract][Full Text] [Related]
12. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
[TBL] [Abstract][Full Text] [Related]
13. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid.
Simats A; Ramiro L; Montaner J; García-Berrocoso T
Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415
[TBL] [Abstract][Full Text] [Related]
14. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
15. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases.
Zhang J; Goodlett DR; Montine TJ
J Alzheimers Dis; 2005 Mar; 8(4):377-86. PubMed ID: 16556969
[TBL] [Abstract][Full Text] [Related]
16. Toward defining the anatomo-proteomic puzzle of the human brain: An integrative analysis.
Fernandez-Irigoyen J; Labarga A; Zabaleta A; de Morentin XM; Perez-Valderrama E; Zelaya MV; Santamaria E
Proteomics Clin Appl; 2015 Oct; 9(9-10):796-807. PubMed ID: 25418211
[TBL] [Abstract][Full Text] [Related]
17. Developing new methods to answer old and new questions in neurodegenerative diseases: 21(st) Workshop of the HUPO Brain Proteome Project (HBPP) 23-24 January 2014, Honolulu, Hawaii.
El Magraoui F; Eisenacher M; Schrötter A; Kuhlmann K; Heinsen H; Andrén P; Nilsson P; Häggmark A; Schmitz G; Verhaert P; Borchers C; Yoo JS; Lee BH; Meyer HE; Grinberg LT
Proteomics; 2014 Jun; 14(11):1308-10. PubMed ID: 24753468
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
19. The human CSF pain proteome.
Khoonsari PE; Ossipova E; Lengqvist J; Svensson CI; Kosek E; Kadetoff D; Jakobsson PJ; Kultima K; Lampa J
J Proteomics; 2019 Jan; 190():67-76. PubMed ID: 29852297
[TBL] [Abstract][Full Text] [Related]
20. CSF Sample Preparation for Data-Independent Acquisition.
Barkovits K; Tönges L; Marcus K
Methods Mol Biol; 2019; 2044():61-67. PubMed ID: 31432406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
